Viridian Therapeutics, Inc. 13F holders
214 funds reported a position in Viridian Therapeutics, Inc. in their 13F for the quarter ended 30 June 2026, together 136.0 million shares worth $2.50 billion. Against the quarter before, 41 opened a position, 95 added, 49 trimmed and 56 sold out; together they bought a net 23.6 million shares. The largest holders: FMR LLC, BlackRock, Inc. and Bellevue Group AG.
Funds holding214-11 on Q1 2026
Shares they held136.0Mworth $2.50 billion
Net bought on the quarter23.6M sharesabout $434.5 million at the funds' values
Funds buying to selling136 to 105opened or added, to cut or sold
Opened 41Added 95Held 27Trimmed 49Sold out 56
What each fund did in VRDN against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in VRDN in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 19 reported a position in Viridian Therapeutics, Inc.: 2 opened one, 7 added, 2 trimmed and 4 sold out, a net 119,946 shares sold.
| Fund | Change in shares | Shares now | Status | Filing |
|---|---|---|---|---|
| Fideuram - Intesa Sanpaolo Private Banking S.p.a. | -92,139 | 9 | trimmed | 13F |
| Ami Asset Management Corp. | +49,959 | 49,959 | new | 13F |
| Hennion & Walsh Asset Management, Inc. | +45,673 | 254,765 | added | 13F |
| J. Safra Sarasin Holding AG | +9,729 | 117,568 | added | 13F |
| Sterling Capital Management LLC | +399 | 2,061 | added | 13F |
| SBI Securities Co., Ltd. | -353 | 214 | trimmed | 13F |
| Gamma Investing LLC | +338 | 800 | added | 13F |
| Nisa Investment Advisors, LLC | +189 | 1,887 | added | 13F |
| Farther Finance Advisors, LLC | +100 | 438 | added | 13F |
| SJS Investment Consulting Inc. | +47 | 157 | added | 13F |
| Assetmark, Inc. | +14 | 14 | new | 13F |
| Doliver Advisors, LP | -30,000 | 0 | sold out | 13F |
| Eleva Capital SAS | -7,126 | 0 | sold out | 13F |
| Wealth Enhancement Trust Services, Inc. | -20 | 0 | sold out | 13F |
| Y-Intercept (Hong Kong) Ltd | -96,756 | 0 | sold out | 13F |
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 5 reported a position in Viridian Therapeutics, Inc. in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 16.6 million shares worth $305.0 million, 0.0% of its reported book. Sold out: Two Sigma Investments, Millennium Management. In the quarter, 4 funds added or opened a position and 3 trimmed or sold out; together they bought a net 1.5 million shares, about $28.1 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| FMR LLC | 16,604,740 | $305.0 million | 0.0% | +1,225,363 | added | 30 June 2026 | 13F |
| Geode Capital Management | 2,501,869 | $46.0 million | 0.0% | +168,656 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 2,343,208 | $43.0 million | 0.1% | +2,020,372 | added | 30 June 2026 | 13F |
| Renaissance Technologies | 768,600 | $14.1 million | 0.0% | +565,500 | added | 30 June 2026 | 13F |
| Citadel Advisors | 41,303 | $758,736 | 0.0% | -2,276,931 | trimmed | 30 June 2026 | 13F |
| Two Sigma Investments | 0 | $0 | 0.0% | -35,114 | exited | 30 June 2026 | 13F |
| Millennium Management | 0 | $0 | 0.0% | -140,595 | exited | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 16,604,740 | 12.21% | $305.0 million | 0.01% | +1,225,363 | 13F |
| BlackRock, Inc. | 8,551,488 | 6.29% | $157.1 million | 0.00% | +720,013 | 13F |
| Bellevue Group AG | 6,731,909 | 4.95% | $123.7 million | 2.60% | +5,765 | 13F |
| Paradigm Biocapital Advisors LP | 6,723,788 | 4.94% | $123.5 million | 2.31% | +3,574,895 | 13F |
| Kynam Capital Management, LP | 6,453,877 | 4.74% | $118.6 million | 6.55% | +4,112,225 | 13F |
| State Street Corp. | 6,124,976 | 4.50% | $112.5 million | 0.00% | +1,452,091 | 13F |
| Price T Rowe Associates Inc. | 5,748,410 | 4.23% | $105.6 million | 0.01% | +2,542,375 | 13F |
| Fairmount Funds Management LLC | 5,090,928 | 3.74% | $93.5 million | 6.18% | +1,176,470 | 13F |
| Vanguard Capital Management LLC | 4,576,860 | 3.36% | $84.1 million | 0.00% | +409,659 | 13F |
| Deep Track Capital, LP | 3,592,740 | 2.64% | $66.0 million | 0.97% | +2,198,796 | 13F |
| Venrock Adviser, LLC | 3,257,917 | 2.39% | $59.8 million | 1.81% | -624,792 | 13F |
| Wellington Management Group LLP | 3,128,362 | 2.30% | $57.5 million | 0.01% | +49,808 | 13F |
| Vanguard Portfolio Management LLC | 2,752,827 | 2.02% | $50.6 million | 0.00% | +1,111,350 | 13F |
| Geode Capital Management, LLC | 2,501,869 | 1.84% | $46.0 million | 0.00% | +168,656 | 13F |
| Avoro Capital Advisors LLC | 2,500,000 | 1.84% | $45.9 million | 0.41% | +1,000,000 | 13F |
| Baker Bros. Advisors LP | 2,383,025 | 1.75% | $43.8 million | 0.22% | +411,347 | 13F |
| Point72 Asset Management, L.P. | 2,343,208 | 1.72% | $43.0 million | 0.07% | +2,020,372 | 13F |
| Caligan Partners LP | 2,193,981 | 1.61% | $40.3 million | 1.94% | new | 13F |
| Novo Holdings A/s | 2,135,000 | 1.57% | $39.2 million | 2.28% | +135,000 | 13F |
| Tang Capital Management LLC | 1,792,626 | 1.32% | $32.9 million | 1.50% | no change | 13F |
| Fisher Asset Management, LLC | 1,750,850 | 1.29% | $32.2 million | 0.01% | -17,445 | 13F |
| Candriam S.C.A. | 1,707,698 | 1.26% | $31.3 million | 0.14% | +995,959 | 13F |
| Goldman Sachs Group Inc. | 1,691,304 | 1.24% | $31.1 million | 0.00% | +99,359 | 13F |
| First Turn Management, LLC | 1,670,000 | 1.23% | $30.7 million | 3.28% | +758,663 | 13F |
| Dimensional Fund Advisors LP | 1,611,521 | 1.18% | $29.6 million | 0.01% | +1,081,758 | 13F |
| AllianceBernstein L.P. | 1,391,639 | 1.02% | $27.2 million | 0.01% | -433 | 13F |
| UBS Group AG | 1,428,843 | 1.05% | $26.2 million | 0.00% | +1,121,709 | 13F |
| Parkman Healthcare Partners LLC | 1,377,576 | 1.01% | $25.3 million | 2.60% | +819,640 | 13F |
| Balyasny Asset Management L.P. | 1,279,859 | 0.94% | $23.5 million | 0.04% | -1,036,098 | 13F |
| D. E. Shaw & Co., Inc. | 1,182,222 | 0.87% | $21.7 million | 0.01% | -80,318 | 13F |
| Rice Hall James & Associates, LLC | 1,175,906 | 0.86% | $21.6 million | 1.05% | +277,295 | 13F |
| Arrowstreet Capital, Limited Partnership | 1,112,413 | 0.82% | $20.4 million | 0.01% | +1,089,134 | 13F |
| BNP Paribas Financial Markets | 1,012,138 | 0.74% | $18.6 million | 0.01% | +745,739 | 13F |
| UBS AM, a distinct business unit of UBS Asset Management Americas LLC | 999,915 | 0.74% | $18.4 million | 0.00% | +111,617 | 13F |
| Elmind Capital, LP | 984,931 | 0.72% | $18.1 million | 4.55% | +450,000 | 13F |
| Bank of America Corp. | 944,345 | 0.69% | $17.3 million | 0.00% | -219,270 | 13F |
| Northern Trust Corp. | 863,491 | 0.63% | $15.9 million | 0.00% | +166,492 | 13F |
| Eversept Partners, LP | 831,142 | 0.61% | $15.3 million | 0.83% | +117,873 | 13F |
| Charles Schwab Investment Management Inc. | 815,027 | 0.60% | $15.0 million | 0.00% | +87,090 | 13F |
| Schonfeld Strategic Advisors LLC | 793,508 | 0.58% | $14.6 million | 0.08% | new | 13F |
| Renaissance Technologies LLC | 768,600 | 0.56% | $14.1 million | 0.02% | +565,500 | 13F |
| Morgan Stanley | 728,817 | 0.54% | $13.4 million | 0.00% | -141,345 | 13F |
| Woodline Partners LP | 700,929 | 0.52% | $12.9 million | 0.04% | no change | 13F |
| JPMorgan Chase & Co. | 639,929 | 0.47% | $12.1 million | 0.00% | -419,935 | 13F |
| Vanguard Fiduciary Trust Co. | 657,588 | 0.48% | $12.1 million | 0.00% | +66,363 | 13F |
| Perceptive Advisors LLC | 581,980 | 0.43% | $10.7 million | 0.17% | -588,849 | 13F |
| Boothbay Fund Management, LLC | 541,058 | 0.40% | $9.9 million | 0.19% | new | 13F |
| Emerald Advisers, LLC | 537,328 | 0.39% | $9.9 million | 0.23% | new | 13F |
| Deutsche Bank AG | 482,875 | 0.35% | $8.9 million | 0.00% | -549,441 | 13F |
| Algert Global LLC | 482,237 | 0.35% | $8.9 million | 0.10% | -81,762 | 13F |
The 50 largest of the 214 funds that reported a position in VRDN in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Options the funds reported on VRDN
| Fund | Option | Shares under the options | Value of those shares | Quarter ended | Filing |
|---|---|---|---|---|---|
| Citadel Advisors | Calls | 139,100 | $2.6 million | 30 June 2026 | 13F |
| Citadel Advisors | Puts | 31,200 | $573,144 | 30 June 2026 | 13F |
| Point72 Asset Management | Calls | 13,000 | $238,810 | 30 June 2026 | 13F |
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read more
They are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 20 August 2026 | 13G | Point72 Asset Management, L.P. and 5 others | 5.7 million | 5.0% | 19 August 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 14 August 2026 | 13G/A | Kynam Capital Management, LP and 5 others | 0 | 5.7% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 14 August 2026 | 13G/A | Deep Track Capital, LP and 5 others | 3.6 million | 3.2% | 30 June 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 14 August 2026 | 13G/A | Paradigm BioCapital Advisors LP and 7 others | 6.7 million | 6.1% | 30 June 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 14 August 2026 | 13G | T. Rowe Price Associates, Inc. and 1 other | 5.7 million | 5.2% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 7 August 2026 | 13G | State Street Corporation and 1 other | 6.1 million | 5.5% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 26 June 2026 | 13G | Paradigm BioCapital Advisors LP and 7 others | 5.6 million | 5.1% | 18 June 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 15 May 2026 | 13G | Bellevue Group AG and 3 others | 6.7 million | 6.6% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 13 May 2026 | 13D/A | Fairmount Funds Management LLC and 1 other | 17.2 million | 14.0% | 11 May 2026 | Item 4 is hereby amended and supplemented as follows: Fund II purchased the shares of Common Stock referenced in Item 3 for investment purposes. | EDGAR |
| 8 May 2026 | 13G | Deep Track Capital, LP and 5 others | 5.4 million | 5.3% | 1 May 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 27 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 17 February 2026 | 13G/A | Kynam Capital Management, LP and 5 others | 1.5 million | 1.5% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 13 February 2026 | 13G/A | Deep Track Capital, LP and 5 others | 2.5 million | 2.6% | 31 December 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 14 November 2025 | 13G/A | Commodore Capital LP and 3 others | 3.2 million | 3.9% | 30 September 2025 | passive, under 20% (13d-1(c)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 30 September 2026 | 3,669 | $20.00 | SEC |
| 25 September 2026 | 3,490 | $20.66 | SEC |
| 24 September 2026 | 8,507 | $21.43 | SEC |
| 22 September 2026 | 51,630 | $21.58 | SEC |
| 17 September 2026 | 1,255 | $22.44 | SEC |
| 9 September 2026 | 4 | $23.17 | SEC |
| 2 September 2026 | 34,891 | $23.03 | SEC |
| 1 September 2026 | 21,100 | $23.16 | SEC |
| 26 August 2026 | 3,561 | $24.18 | SEC |
| 24 August 2026 | 19,375 | $24.29 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.